Page last updated: 2024-11-03

repirinast and Urticaria

repirinast has been researched along with Urticaria in 1 studies

repirinast: structure given in first source

Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.

Research Excerpts

ExcerptRelevanceReference
"We describe the first case of drug-induced solar urticaria due to repirinast, an antiallergic drug developed and introduced into the market in Japan in 1987."7.69Drug-induced solar urticaria due to repirinast. ( Kurumaji, Y; Shono, M, 1994)
"We describe the first case of drug-induced solar urticaria due to repirinast, an antiallergic drug developed and introduced into the market in Japan in 1987."3.69Drug-induced solar urticaria due to repirinast. ( Kurumaji, Y; Shono, M, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurumaji, Y1
Shono, M1

Other Studies

1 other study available for repirinast and Urticaria

ArticleYear
Drug-induced solar urticaria due to repirinast.
    Dermatology (Basel, Switzerland), 1994, Volume: 188, Issue:2

    Topics: Aged; Dermatitis, Photoallergic; Female; Histamine Antagonists; Humans; Quinolones; Sunlight; Ultrav

1994